Clinical Trial Update: Nicotine Treatment of Mild Cognitive Impairment (MCI) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating nicotine as a treatment for mild cognitive impairment (MCI) related to age-related memory disorders. The current status o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Memory Disorders
• Cognitive Impairment

Drugs mentioned

• Nicotine (nicotine)

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Age-Related Memory Disorders | Phase 1 | Status: UNKNOWN